Business Context and Reporting Period
This Form 6-K filing by Bon Natural Life Ltd, dated November 8, 2022, reports on corporate governance actions rather than financial performance. The company is a foreign private issuer based in Xi'an, China, with principal executive offices in the Xi'an Hi-Tech Zone.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on structural changes to the company's charter and equity plans.
Material Changes
- Amended and Restated Memorandum and Articles (M&A): The Board approved a new class of 50,000,000 Preference Shares with a par value of $0.0001. Concurrently, authorized ordinary shares were reduced from 500,000,000 to 450,000,000.
- Shareholder Voting Rights: The Amended M&A allows a majority of shareholders to pass ordinary resolutions via written consent, subject to notice requirements.
- Equity Incentive Plan: The Board approved the 2022 Equity Incentive Plan, permitting the grant of stock options, restricted stock, and RSUs. The plan is capped at 15% of issued and outstanding ordinary shares on a fully diluted basis.
Outlook, Risks, and Unusual Items
Management Commentary and Next Steps: The Board has scheduled an Extraordinary General Meeting for November 28, 2022, at 10:00 a.m. Beijing time to seek shareholder approval for the Amended M&A and the Equity Incentive Plan. Shareholders of record as of October 28, 2022, are entitled to vote.
Risks and Contingencies: The implementation of the new share structure and incentive plan is contingent upon the approval of the majority of shareholders at the upcoming meeting.
Key Facts for Investor Verification
- Confirmation of shareholder approval for the Amended M&A and Equity Incentive Plan at the November 28, 2022 meeting.
- Details on the specific rights, preferences, and limitations of the newly authorized Preference Shares once designated by the Board.
- Impact of the 15% equity incentive cap on future dilution of existing ordinary shareholders.
- Verification of the reduction in authorized ordinary shares from 500 million to 450 million.